Skip to content

Bone Marrow Concentrate (BMC) Injection in Intervertebral Discs

Study of Bone of Marrow Concentrate (BMC) Injection in Discs, Facets, Sacroiliac Joints, and Epidural Space for Chronic Lower Back Pain With and Without Radiculopathy

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04559295
Enrollment
80
Registered
2020-09-22
Start date
2018-11-21
Completion date
2021-04-30
Last updated
2020-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthropathy Vertebrae, Disc Degeneration, Disc Disease, Low Back Pain, Radiculopathy, Sacral Disorder, Spinal Stenosis

Keywords

Stem cells, Bone marrow concentrate, Disc, Minimally invasive, Injections, Facet joint, Sacroiliac joint, Epidural space

Brief summary

Intradiscal delivery of bone marrow concentrate (BMC) into discs, facet, epidural space, and sacroiliac joints

Detailed description

To study if the outcomes for the injection of bone marrow concentrate (BMC) in patients with disc, facet, epidural space, and sacroiliac joint pain create a clinically meaningful improvement in pain and function. Further analysis will determine if there be any variance in patient reported outcome due to the individual's pre-procedure cell count and analysis. Hypothesis 1: An injection of autologous BMC into discs, facets, sacroiliac joints, and epidural space will improve pain and function in patients with IDD Hypothesis 2: There will be a direct relationship between an individual's BMC composition and the patient's reported outcomes

Interventions

The intradiscal delivery of bone marrow concentrate (BMC) into discs, facet , epidural space, and sacroiliac joints

Sponsors

Stem Cures
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Independent Observer was blinded as to wether a subject received treatment or was in the control group.

Intervention model description

A prospective evaluation of a cohort of patients with a specific characteristic over time to see if they develop a particular endpoint or outcome based on a stated hypothesis.

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* A high index of suspicion for discogenic pain, i.e. painful degenerative discs with or without protrusions/herniations and facet/sacroiliac joint pain * Patients with mild to severe spinal stenosis * Patients with radiculopathy * Patients with disc extrusions * Patients with failed spinal fusion * Patients with mild to severe facet arthropathy * Patients with suspected sacroiliac joint disease * Age 18 to 60 years * Mild to severe loss of intervertebral disc height * Pain is not responsive to conservative treatment measures (oral medication, epidural steroid injections, physical therapy) * Pain persists for an extended period of time (i.e., at least 3 months) * High intensity zone (HIZ) in annular fissure or adjacent to annular fissure detected on T2 or STIR MRI * No evidence of contraindications to undergo procedure such as pregnancy, active infection, bleeding disorder, or metastatic cancer * English speaking

Exclusion criteria

* Spinal Deformity (Scoliosis \>20 degrees, Spondylolisthesis) * Sequestered fragments, severe thecal sac compression * Severe neurologic deficit * Non-English speaking * Bone marrow disorders * Immunosuppressed Patients * Patients with coagulopathy * Localized infection in the area of skin penetration * Spinal infection * Serious medical co-morbidities

Design outcomes

Primary

MeasureTime frameDescription
Oswestry Disability Index (ODI)Two YearsThe Oswestry Disability Index (ODI) is a questionnaire used by clinicians and researchers to quantify disability for low back pain. Scale for the ODI is from 0 (best) - 100 (worst).

Secondary

MeasureTime frameDescription
Visual Analog Scale (VAS) for back painTwo YearsWhen responding to a VAS item, respondents specify their level of agreement to a statement by indicating a position along a continuous line between two end-points. Scale for VAS for back pain is from 0 (best) - 10 (worst).
Visual Analog Scale (VAS) for leg painTwo YearsWhen responding to a VAS item, respondents specify their level of agreement to a statement by indicating a position along a continuous line between two end-points. Scale for VAS for leg pain is from 0 (best) - 10 (worst).
PROMIS Physical HealthTwo YearsThe PROMIS Global-10 is a publicly available global health assessment tool that allows measurements of symptoms, functioning, and healthcare-related quality of life (HRQoL) for a wide variety of chronic diseases and conditions. Scale for PROMIS Physical Health is from 16.2 (worst) - 67.7 (best)
Numeric Rating Scale (NRS)Two YearsThe NRS consists of a numeric version of the visual analog scale. It is labeled from zero to ten, with zero being an example of someone with no pain and ten being the worst pain possible. Scale for NRS is from 0 (best) - 10 (worst).
North American Spine Society (NASS) for patient satisfactionTwo YearsThe North American Spine Society (NASS) developed an outcome assessment instrument to measure diverse dimensions of the impact of lumbar spine problems. Scale range is from 1 to 4 (best to worst).
EURO Quality of Life (EuroQol)Two YearsEuroQol is an instrument which evaluates the generic quality of life developed in Europe and widely used. Scale is from 0.33 (worst - 0.88 (best).
PROMIS Mental HealthTwo YearsThe PROMIS Global-10 is a publicly available global health assessment tool that allows measurements of symptoms, functioning, and healthcare-related quality of life (HRQoL) for a wide variety of chronic diseases and conditions. Scale for PROMIS Mental Health is from 21.2 (worst) - 67.6 (best).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026